Cardiovascular risk factors, smoking and kidney function

Homoarginine, kidney function and cardiovascular mortality risk.

BACKGROUND Homoarginine is a novel biomarker for cardiovascular diseases. In the present large cohort study, we evaluate how homoarginine is linked to kidney function and examine the potential interaction of homoarginine and kidney function as predictors of cardiovascular outcomes. METHODS Serum homoarginine (mean: 2.41 ± 1.05 µmol/L), cystatin C and creatinine-based estimated GFR (eGFR, mean...

Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youths.

BACKGROUND Aboriginal populations in North America are exhibiting an increased prevalence of cardiovascular disease and associated traditional and nontraditional cardiovascular risk factors, trends believed to be due to the influence of Western lifestyle habits. Because these influences are present at an early age, we sought to study the patterns of one such habit, cigarette smoking, among Abor...

Urinary Retinol-Binding Protein: Relationship to Renal Function and Cardiovascular Risk Factors in Chronic Kidney Disease

The role of urinary retinol-binding protein (RBP) as a biomarker of CKD in proximal tubular diseases, glomerulopathies and in transplantation is well established. However, whether urinary RBP is also a biomarker of renal damage and CKD progression in general CKD is not known. In this study, we evaluated the association of urinary RBP with renal function and cardiovascular risk factors in the ba...

Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension.

OBJECTIVE To investigate the clinical usefulness of serum cystatin C (Scys) and cystatin C-based equations for the screening of chronic kidney disease in primary hypertensive patients, and correlate these markers with risk factors for cardiovascular disease. METHODS A cross-sectional study was performed in 199 middle-aged adults at a basic health unit. Kidney function assessment included meas...

Cigarette Smoking and Cardiovascular Risk in Young Women with Polycystic Ovary Syndrome